FDA’s Opdivo Lung Cancer Approval

By João L. Carapinha

October 11, 2024

The FDA has approved a new treatment regimen using Opdivo (nivolumab) for resectable non-small cell lung cancer (NSCLC), marking a significant advancemen...
The VA’s Journey with Early Adoption of AI in Healthcare
Enhancing Care in Abu Dhabi: The New ABA Guidelines for Autism
Hip Fracture Risk in Elderly Adults: Evaluating Prediction Tools
In Saudi Arabia, the Hevolution Foundation is Reshaping Ageing Research
Thailand’s Healthcare System and the Role of HTA: A Model of Universal ...
Enhancing Osteoarthritis Management Through Health Economics
The Impact of the AI Act on the Healthcare Sector in Europe
A Value Framework for Next-Generation Sequencing in Europe: Access to Precisi...
Addressing the Challenges of Value Attribution in Combination Therapies
Extension of BowelScreen to Ages 50-54: A Cost-Effectiveness Analysis
Understanding the Cost and Funding of Gene Therapies
Transformation of Health Technology Assessment in Türkiye